Ownership and insider activity for Outset Medical, Inc. (OM): insider transactions, US Senate and House trading disclosures and shares outstanding. Track how corporate insiders and politicians are trading the stock.
Outset Medical, Inc. is a medical technology firm that specializes in developing hemodialysis systems. The company's primary product is the Tablo Hemodialysis System, a compact console designed to deliver dialysis treatment in various environments, including hospitals and patients' homes. This innovative system boasts integrated water purification, on-demand production of dialysate, and advanced software complete with connectivity features.
Price
| Price | $3.10 |
| Market Cap | $57M |
| Exchange | NASDAQ |
| Country | US |
Recent Insider Transactions
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 2026-08-17 | Trigg Leslie | S-Sale | 3,437 | $15K |
| 2026-08-17 | Brottem John L. | S-Sale | 2,632 | $12K |
| 2026-08-17 | Gaeta Renee | S-Sale | 4,543 | $20K |
| 2026-06-26 | Brottem John L. | A-Award | 59,830 | |
| 2026-06-26 | Gaeta Renee | A-Award | 71,630 | |
| 2026-06-26 | Trigg Leslie | A-Award | 99,160 | |
| 2026-06-04 | HACKETT PATRICK T | A-Award | 10,667 | |
| 2026-06-04 | OBOYLE KEVIN C | A-Award | 10,667 | |
| 2026-06-04 | Prange Karen | A-Award | 10,667 | |
| 2026-06-04 | LANG BRENT D. | A-Award | 10,667 |
Balance Sheet (10y)
| Year | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $33.3M | $36.9M | $295.0M | $182.3M | $73.2M | $68.5M | $124.0M | $35.0M |
| Short-term Investments | $109.5M | $33.2M | $19.9M | $157.1M | $214.3M | $134.8M | $34.7M | $133.9M |
| Receivables | $1.1M | $3.9M | $6.5M | $25.6M | $28.1M | $33.0M | $35.6M | $28.3M |
| Inventory | $3.0M | $4.6M | $18.4M | $39.2M | $51.5M | $49.2M | $59.4M | $47.6M |
| Total Current Assets | $147.6M | $79.6M | $345.9M | $409.8M | $373.6M | $291.2M | $258.2M | $250.9M |
| Property, Plant & Equipment | $2.9M | $7.9M | $23.3M | $20.2M | $22.0M | $18.6M | $12.1M | $9.5M |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Assets | $151.1M | $88.4M | $403.8M | $463.5M | $400.1M | $313.8M | $275.8M | $264.5M |
| Accounts Payable | $3.4M | $5.0M | $4.9M | $1.8M | $603000 | $5.8M | $3.9M | $554000 |
| Short-term Debt | $10000 | $7.5M | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Current Liabilities | $10.2M | $24.9M | $36.7M | $51.7M | $51.9M | $55.3M | $45.4M | $37.6M |
| Long-term Debt | $28.3M | $21.6M | $29.7M | $29.8M | $96.3M | $130.1M | $197.4M | $96.2M |
| Total Liabilities | $439.1M | $460.6M | $75.2M | $89.4M | $154.1M | $190.9M | $249.0M | $137.5M |
| Retained Earnings | -$287.9M | -$372.6M | -$494.1M | -$626.0M | -$789.0M | -$961.7M | -$1.09B | -$1.17B |
| Total Equity | -$287.9M | -$372.2M | $328.6M | $374.1M | $246.0M | $122.9M | $26.8M | $127.0M |
| Total Debt | $28.9M | $29.1M | $38.6M | $37.8M | $103.2M | $136.2M | $201.9M | $101.2M |
| Net Debt | -$113.9M | -$41.0M | -$276.3M | -$301.7M | -$184.3M | -$67.1M | $43.2M | -$67.7M |
| Working Capital | $137.4M | $54.7M | $309.2M | $358.1M | $321.7M | $235.9M | $212.8M | $213.3M |
Financial Health
| Debt / Equity | 1.08 |
| Current Ratio | 5.19 |
Profitability
| Return on Equity | -62.25% |
| Return on Invested Capital | -32.84% |
| Return on Assets | -30.65% |
| Gross Margin | 41.76% |
| Operating Margin | -56.06% |
| Net Margin | -63.06% |
Related companies: CATX · HSDT · INGN · NNOX · OMI · QTRX · SI
Explore sector: Healthcare · Medical - Devices
More sections of OM: Overview · Financials · Valuation · Statistics · Estimates · Technical · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks